{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:30:46Z","timestamp":1787020246229,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chongqing medical scientific research project (Joint project of Chongqing Health Commission and Science and Technology Bureau) of China","award":["2020FYYX067"],"award-info":[{"award-number":["2020FYYX067"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic cancer is the foremost contributor to cancer-related deaths globally, and its prevalence continues to rise annually. Nevertheless, the underlying mechanisms behind its development remain unclear and necessitate comprehensive investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, a total of 29 fresh stool samples were collected from patients diagnosed with pancreatic cancer. The gut microbial data of healthy controls were obtained from the SRA database (SRA data number: SRP150089). Additionally, 28 serum samples and diseased tissues were collected from 14 patients with confirmed pancreatic cancer and 14 patients with chronic pancreatitis. Informed consent was obtained from both groups of patients. Microbial sequencing was performed using 16s rRNA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The results showed that compared with healthy controls, the species abundance index of intestinal flora in patients with pancreatic cancer was increased (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05), and the number of beneficial bacteria at the genus level was reduced (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Compared with patients with chronic pancreatitis, the expression levels of CA242 and CA199 in the serum of patients with pancreatic cancer were increased (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). The bacterial richness index of tumor microorganisms in patients with pancreatic cancer increased, while the diversity index decreased(\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Furthermore, there was a change in the species composition at the genus level. Additionally, the expression level of CA242 was found to be significantly positively correlated with the relative abundance of Acinetobacter(\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Over all, the expression levels of serum tumor markers CA242 and CA19-9 in patients with pancreatic cancer are increased, while the beneficial bacteria in the intestine and tumor microenvironment are reduced and pathogenic bacteria are increased. Acinetobacter is a specific bacterial genus highly expressed in pancreatic cancer tissue.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-024-12202-z","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T11:02:21Z","timestamp":1713178941000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Heterogeneous changes in gut and tumor microbiota in patients with pancreatic cancer: insights from clinical evidence"],"prefix":"10.1186","volume":"24","author":[{"given":"Feng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjiang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,15]]},"reference":[{"issue":"1","key":"12202_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"12202_CR2","doi-asserted-by":"publisher","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","volume":"4","author":"L Rahib","year":"2021","unstructured":"Rahib L, Wehner MR, Matrisian LM, et al. Estimated projection of US Cancer incidence and death to 2040. JAMA Netw Open. 2021;4(4):e214708. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.4708.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"12202_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10238-013-0234-9","volume":"14","author":"JC Gui","year":"2014","unstructured":"Gui JC, Yan WL, Liu XD, et al. CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis. Clin Exp Med. 2014;14(2):225\u201333. https:\/\/doi.org\/10.1007\/s10238-013-0234-9.","journal-title":"Clin Exp Med"},{"key":"12202_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-94-017-7215-015","volume":"867","author":"S Scara","year":"2015","unstructured":"Scara S, Bottoni P, Scatena R, et al. CA 19\u2013\u20099: biochemical and clinical aspects. Adv Cancer Biomarkers: Biochem Clin Crit Revision. 2015;867:247\u201360. https:\/\/doi.org\/10.1007\/978-94-017-7215-015.","journal-title":"Adv Cancer Biomarkers: Biochem Clin Crit Revision"},{"key":"12202_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/bs.pmbts.2018.12.007","volume":"162","author":"HQ Dou","year":"2019","unstructured":"Dou HQ, Sun GR, Zhang LJ, et al. CA242 as a biomarker for pancreatic cancer and other diseases. Prog Mol Biol Transl. 2019;162:229\u201339. https:\/\/doi.org\/10.1016\/bs.pmbts.2018.12.007.","journal-title":"Prog Mol Biol Transl"},{"issue":"4","key":"12202_CR6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/bjc.1991.146","volume":"63","author":"P Kuusela","year":"1991","unstructured":"Kuusela P, Haglund C, Roberts PJ, et al. Comparison of a new tumour marker CA 242 with CA 19\u2013\u20099, CA 50 and carci noembryonic antigen (CEA) in digestive tract diseases. Br J Cancer. 1991;63(4):636\u201340. https:\/\/doi.org\/10.1038\/bjc.1991.146.","journal-title":"Br J Cancer"},{"issue":"1","key":"12202_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers15010001","volume":"15","author":"C Binda","year":"2022","unstructured":"Binda C, Gibiino G, Sbrancia M, et al. Microbiota in the natural history of pancreatic Cancer: from Predispos ition to Therapy. Cancers. 2022;15(1):1. https:\/\/doi.org\/10.3390\/cancers15010001.","journal-title":"Cancers"},{"issue":"6","key":"12202_CR8","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/gutjnl-2017-315084","volume":"68","author":"Z Ren","year":"2018","unstructured":"Ren Z, Li A, Jiang J, et al. Gut microbiome analysis as a tool towards targeted non-invasive biomar kers for early hepatocellular carcinoma. Gut. 2018;68(6):1014\u201323. https:\/\/doi.org\/10.1136\/gutjnl-2017-315084.","journal-title":"Gut"},{"key":"12202_CR9","doi-asserted-by":"publisher","first-page":"154131","DOI":"10.1016\/j.prp.2022.154131","volume":"239","author":"SA Mozaffari","year":"2022","unstructured":"Mozaffari SA, Salehi A, Mousavi E, et al. SARS-CoV-2-associated gut microbiome alteration; a new contributor to colorectal cancer pathogenesis. Pathol Res Pract. 2022;239:154131. https:\/\/doi.org\/10.1016\/j.prp.2022.154131.","journal-title":"Pathol Res Pract"},{"issue":"5","key":"12202_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/carcin\/bgz116","volume":"41","author":"R Mendez","year":"2020","unstructured":"Mendez R, Kesh K, Arora N, et al. Microbial dysbiosis and polyamine metabolism as predictive markers for early detection of pancreatic cancer. Carcinogenesis. 2020;41(5):561\u201370. https:\/\/doi.org\/10.1093\/carcin\/bgz116.","journal-title":"Carcinogenesis"},{"issue":"56","key":"12202_CR11","doi-asserted-by":"publisher","first-page":"95176","DOI":"10.18632\/oncotarget.18820","volume":"8","author":"Z Ren","year":"2017","unstructured":"Ren Z, Jiang J, Xie H, et al. Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China. Oncotarget. 2017;8(56):95176\u201391. https:\/\/doi.org\/10.18632\/oncotarget.18820.","journal-title":"Oncotarget"},{"issue":"2","key":"12202_CR12","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.1016\/j.cgh.2020.11.006","volume":"20","author":"S Kohi","year":"2022","unstructured":"Kohi S, Macgregor-Das A, Dbouk M. Alterations in the duodenal fluid microbiome of patients with pancreatic Cancer. Clin Gastroenterol Hepatol. 2022;20(2):e196\u2013227. https:\/\/doi.org\/10.1016\/j.cgh.2020.11.006.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6356","key":"12202_CR13","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller LT, Barzily-Rokni M, Danino T, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357(6356):1156\u201360. https:\/\/doi.org\/10.1126\/science.aah5043.","journal-title":"Science"},{"issue":"4","key":"12202_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme E, Zhang Y, Zhang L, et al. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer outcomes. Cell. 2019;178(4):795\u2013e806712. https:\/\/doi.org\/10.1016\/j.cell.2019.07.008.","journal-title":"Cell"},{"issue":"17","key":"12202_CR15","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, et al. FASTP: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34(17):i884. https:\/\/doi.org\/10.1093\/bioinformatics\/bty560.","journal-title":"Bioinformatics"},{"issue":"21","key":"12202_CR16","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/bioinformatics\/btr507","volume":"27","author":"T Magoc","year":"2011","unstructured":"Magoc T, Salzberg SL, et al. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 2011;27(21):2957\u201363. https:\/\/doi.org\/10.1093\/bioinformatics\/btr507.","journal-title":"Bioinformatics"},{"issue":"10","key":"12202_CR17","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/nmeth.2604","volume":"10","author":"RC Edgar","year":"2013","unstructured":"Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10(10):996\u20138. https:\/\/doi.org\/10.1038\/nmeth.2604.","journal-title":"Nat Methods"},{"issue":"16","key":"12202_CR18","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1128\/AEM.00062-07","volume":"73","author":"Q Wang","year":"2007","unstructured":"Wang Q, Garrity GM, Tiedje JM, et al. Naive bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73(16):5261\u20137. https:\/\/doi.org\/10.1128\/AEM.00062-07.","journal-title":"Appl Environ Microbiol"},{"issue":"23","key":"12202_CR19","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1128\/AEM.01541-09","volume":"75","author":"PD Schloss","year":"2009","unstructured":"Schloss PD, Westcott SL, Ryabin T, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75(23):7537\u201341. https:\/\/doi.org\/10.1128\/AEM.01541-09.","journal-title":"Appl Environ Microbiol"},{"key":"12202_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-1-4939-6685-1_9","volume":"1537","author":"B Lawley","year":"2017","unstructured":"Lawley B, Tannock GW. Analysis of 16S rRNA gene amplicon sequences using the QIIME Software Package. Methods Mol Biol. 2017;1537:153\u201363. https:\/\/doi.org\/10.1007\/978-1-4939-6685-1_9.","journal-title":"Methods Mol Biol"},{"issue":"12","key":"12202_CR21","doi-asserted-by":"publisher","first-page":"e018175","DOI":"10.1053\/j.gastro.2020.12.039","volume":"7","author":"L Ge","year":"2017","unstructured":"Ge L, Pan B, Song F, et al. Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy. BMJ Open. 2017;7(12):e018175. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.039.","journal-title":"BMJ Open"},{"issue":"2","key":"12202_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ejso.2004.09.007","volume":"31","author":"XG Ni","year":"2005","unstructured":"Ni XG, Bai XF, Mao YL, et al. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Eur J Surg Oncol. 2005;31(2):164\u20139. https:\/\/doi.org\/10.1016\/j.ejso.2004.09.007.","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"12202_CR23","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1053\/j.gastro.2020.12.039","volume":"160","author":"S Kaur","year":"2021","unstructured":"Kaur S, Jain M, Batra SK. Liquid biopsy for identification of high-risk cystic lesions of Pancre as. Gastroenterology. 2021;160(4):1016\u20138. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.039.","journal-title":"Gastroenterology"},{"key":"12202_CR24","doi-asserted-by":"publisher","first-page":"763902","DOI":"10.3389\/fmolb.2021.763902","volume":"8","author":"J Han","year":"2024","unstructured":"Han J, Li Q, Chen Y, et al. Recent metabolomics analysis in Tumor Metabolism Reprogramming. Front Mol Biosci. 2024;8:763902. https:\/\/doi.org\/10.3389\/fmolb.2021.763902.","journal-title":"Front Mol Biosci"},{"issue":"7","key":"12202_CR25","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1136\/gutjnl-2021-326710","volume":"71","author":"R Newsome","year":"2022","unstructured":"Newsome R, Jobin C. Finding clues in unexpected places: detection of pancreatic cancer thr ough the faecal microbiome. Gut. 2022;71(7):1247\u20138. https:\/\/doi.org\/10.1136\/gutjnl-2021-326710.","journal-title":"Gut"},{"issue":"2","key":"12202_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/00365521.2022.2114812","volume":"58","author":"S Hashimoto","year":"2023","unstructured":"Hashimoto S, Tochio T, Funasaka K, et al. Changes in intestinal bacteria and imbalances of metabolites induced in the intestines of pancreatic ductal adenocarcinoma patients in a Japanese population: a preliminary result. Scand J Gastroenterol. 2023;58(2):193\u20138. https:\/\/doi.org\/10.1080\/00365521.2022.2114812.","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"12202_CR27","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/jcsm.12798","volume":"12","author":"L Feng","year":"2021","unstructured":"Feng L, Zhang W, Shen Q, et al. Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut microbiome. J Cachexia Sarcopenia Muscle. 2021;12(6):1553\u201369. https:\/\/doi.org\/10.1002\/jcsm.12798.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"7","key":"12202_CR28","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/s41401-020-00532-0","volume":"42","author":"LL Pan","year":"2021","unstructured":"Pan LL, Li BB, Pan XH, et al. Gut microbiota in pancreatic diseases: possible new therapeutic strategies. Acta Pharmacol Sin. 2021;42(7):1027\u201339. https:\/\/doi.org\/10.1038\/s41401-020-00532-0.","journal-title":"Acta Pharmacol Sin"},{"key":"12202_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-019-1610-8","volume":"19","author":"C Wang","year":"2019","unstructured":"Wang C, Li W, Wang H, et al. Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis i n mice by reducing TNF-\u03b1 and IL-6 levels and functions and by rebalanc ing intestinal microbiota. BMC Microbiol. 2019;19:1\u201312. https:\/\/doi.org\/10.1186\/s12866-019-1610-8.","journal-title":"BMC Microbiol"},{"issue":"1","key":"12202_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12866-022-02465-6","volume":"22","author":"CM Doocey","year":"2022","unstructured":"Doocey CM, Finn K, Murphy C, et al. The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development. BMC Microbiol. 2022;22(1):53. https:\/\/doi.org\/10.1186\/s12866-022-02465-6.","journal-title":"BMC Microbiol"},{"issue":"12","key":"12202_CR31","doi-asserted-by":"publisher","first-page":"e114277","DOI":"10.1371\/journal.pone.0114277","volume":"9","author":"B van den Bogert","year":"2014","unstructured":"van den Bogert B, Meijerink M, Zoetendal EG, et al. Immunomodulatory properties of Streptococcus and Veillonella isolates from the human small intestine microbiota. PLoS ONE. 2014;9(12):e114277. https:\/\/doi.org\/10.1371\/journal.pone.0114277.","journal-title":"PLoS ONE"},{"key":"12202_CR32","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fonc.2020.00382","volume":"10","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Tao X, Xia S, et al. T lymphocytes: a promising immunotherapeutic target for pancreatitis and pancreatic Cancer? Front Oncol. 2020;10:382. https:\/\/doi.org\/10.3389\/fonc.2020.00382.","journal-title":"Front Oncol"},{"issue":"8","key":"12202_CR33","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.2174\/1871530320666200423095700","volume":"20","author":"HK Kandikattu","year":"2020","unstructured":"Kandikattu HK, Venkateshaiah SU, Mishra A. Chronic pancreatitis and the development of pancreatic Cancer. Endocr Metab Immune Disord Drug Targets. 2020;20(8):1182\u2013210. https:\/\/doi.org\/10.2174\/1871530320666200423095700.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"1","key":"12202_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1053\/j.gastro.2018.04.001","volume":"155","author":"V Sethi","year":"2018","unstructured":"Sethi V, Kurtom S, Tarique M, Lavania S, et al. Gut microbiota promotes Tumor Growth in mice by modulating Immune Response. Gastroenterology. 2018;155(1):33\u2013e3736. https:\/\/doi.org\/10.1053\/j.gastro.2018.04.001.","journal-title":"Gastroenterology"},{"issue":"9","key":"12202_CR35","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.18632\/oncotarget.3109","volume":"6","author":"K Mitsuhashi","year":"2015","unstructured":"Mitsuhashi K, Nosho K, Sukawa Y, et al. Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget. 2015;6(9):7209\u201320. https:\/\/doi.org\/10.18632\/oncotarget.3109.","journal-title":"Oncotarget"},{"issue":"4","key":"12202_CR36","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.bbrc.2018.10.169","volume":"506","author":"T Maekawa","year":"2018","unstructured":"Maekawa T, Fukaya R, Takamatsu S, et al. Possible involvement of Enterococcus infection in the pathogenesis of chronic pancreatitis and cancer. Biochem Biophys Res Commun. 2018;506(4):962\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2018.10.169.","journal-title":"Biochem Biophys Res Commun"},{"key":"12202_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fnut.2019.00016","volume":"6","author":"R Tofalo","year":"2019","unstructured":"Tofalo R, Cocchi S, Suzzi G, Polyamines, Microbiota G. Front Nutr. 2019;6:16. https:\/\/doi.org\/10.3389\/fnut.2019.00016.","journal-title":"Front Nutr"},{"issue":"23","key":"12202_CR38","doi-asserted-by":"publisher","first-page":"12978","DOI":"10.3390\/ijms222312978","volume":"22","author":"H Sammallahti","year":"2021","unstructured":"Sammallahti H, Kokkola A, Rezasoltani S, et al. Microbiota alterations and their association with oncogenomic changes in pancreatic Cancer patients. Int J Mol Sci. 2021;22(23):12978. https:\/\/doi.org\/10.3390\/ijms222312978.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"12202_CR39","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41568-018-0050-3","volume":"18","author":"RA Casero Jr","year":"2018","unstructured":"Casero RA Jr., Murray Stewart T, Pegg AE. Polyamine metabolism and cancer: treatments, challenges and opportunities. Nat Rev Cancer. 2018;18(11):681\u201395. https:\/\/doi.org\/10.1038\/s41568-018-0050-3.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"12202_CR40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","volume":"8","author":"S Pushalkar","year":"2018","unstructured":"Pushalkar S, Hundeyin M, Daley D, et al. The pancreatic Cancer Microbiome promotes oncogenesis by induction of Innate and Adaptive Immune suppression. Cancer Discov. 2018;8(4):403\u201316. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-1134.","journal-title":"Cancer Discov"},{"issue":"1","key":"12202_CR41","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s42003-021-02557-5","volume":"4","author":"W Guo","year":"2021","unstructured":"Guo W, Zhang Y, Guo S, et al. Tumor microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer. Commun Biol. 2021;4(1):1019. https:\/\/doi.org\/10.1038\/s42003-021-02557-5.","journal-title":"Commun Biol"},{"issue":"2","key":"12202_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1264\/jsme2.me10179","volume":"26","author":"HJ Doughari","year":"2011","unstructured":"Doughari HJ, Ndakidemi PA, Human IS, et al. The ecology, biology and pathogenesis of Acinetobacter spp.: an overview. Microbes Environ. 2011;26(2):101\u201312. https:\/\/doi.org\/10.1264\/jsme2.me10179.","journal-title":"Microbes Environ"},{"issue":"48","key":"12202_CR43","doi-asserted-by":"publisher","first-page":"7679","DOI":"10.3748\/wjg.v26.i48.7679","volume":"26","author":"AL Wei","year":"2020","unstructured":"Wei AL, Li M, Li GQ, et al. Oral microbiome and pancreatic cancer. World J Gastroenterol. 2020;26(48):7679\u201392. https:\/\/doi.org\/10.3748\/wjg.v26.i48.7679.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"12202_CR44","doi-asserted-by":"publisher","first-page":"1563409","DOI":"10.1080\/20002297.2018.1563409","volume":"11","author":"H Lu","year":"2019","unstructured":"Lu H, Ren Z, Li A, et al. Tongue coating microbiome data distinguish patients with pancreatic head cancer from healthy controls. J Oral Microbiol. 2019;11(1):1563409. https:\/\/doi.org\/10.1080\/20002297.2018.1563409.","journal-title":"J Oral Microbiol"},{"issue":"6494","key":"12202_CR45","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, Livyatan I, Fuks G, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368(6494):973\u201380. https:\/\/doi.org\/10.1126\/science.aay9189.","journal-title":"Science"},{"issue":"7","key":"12202_CR46","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/gutjnl-2021-324755","volume":"71","author":"E Kartal","year":"2022","unstructured":"Kartal E, Schmidt TSB, Molina-Montes E, et al. A faecal microbiota signature with high specificity for pancreatic cancer. Gut. 2022;71(7):1359\u201372. https:\/\/doi.org\/10.1136\/gutjnl-2021-324755.","journal-title":"Gut"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12202-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12202-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12202-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T11:04:22Z","timestamp":1713179062000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12202-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12202"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12202-z","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]},"assertion":[{"value":"31 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the ethics committee of University-Town Hospital of Chongqing Medical University (Approval No. LL-202022).All methods followed guidelines and regulations. Donors gave written imformed consent for tissue collection, testing, and data publication. Samples were coded numerically to safeguard donor confidentiality and privacy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"478"}}